Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Change in Accured Expenses (2019 - 2026)

InMed Pharmaceuticals has reported Change in Accured Expenses over the past 5 years, most recently at -$58348.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 116.23% year-over-year to -$58348.0; the TTM value through Dec 2025 reached -$299364.0, down 458.05%, while the annual FY2025 figure was -$249728.0, 651.5% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$58348.0 at InMed Pharmaceuticals, up from -$274066.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $765664.0 in Q4 2021 and troughed at -$642392.0 in Q3 2024.
  • A 5-year average of -$119721.6 and a median of -$131800.0 in 2022 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 253.19% in 2023 and later surged 312.82% in 2024.
  • Year by year, Change in Accured Expenses stood at $765664.0 in 2021, then plummeted by 145.66% to -$349611.0 in 2022, then skyrocketed by 169.04% to $241378.0 in 2023, then skyrocketed by 48.98% to $359614.0 in 2024, then tumbled by 116.23% to -$58348.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for INM at -$58348.0 in Q4 2025, -$274066.0 in Q3 2025, and -$5431.0 in Q2 2025.